13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q2 2024. See the latest, Q3 2026 →
Reported value
$3.63B
−0.5% on the quarter before
Positions
24
5 new, 3 sold out
Top 10
76.6%
of the value
Est. gain
−$175.2M
on stocks held all quarter
Est. return
−6.1%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, sized at quarter-end prices.
- Humana Inc~$156.9MNew, 0.0% → 4.3% of the portfolio+420,000 shares
- Crh Plc~$113.7MAdded, 6.4% → 8.7% of the portfolio+1,517,059 shares
- Solventum Corp~$96.2MNew, 0.0% → 2.6% of the portfolio+1,820,000 shares
- Wesco Intl Inc~$94.7MAdded, 1.0% → 3.5% of the portfolio+597,276 shares
- Willscot Mobil Mini Hldng Co~$93.0MNew, 0.0% → 2.6% of the portfolio+2,470,000 shares
- Fortrea Hldgs Inc~$66.2MAdded, 0.3% → 2.0% of the portfolio+2,836,563 shares
- Clarivate Plc~$47.4MAdded, 6.2% → 6.1% of the portfolio+8,331,233 shares
- Jazz Pharmaceuticals Plc~$47.0MAdded, 2.7% → 3.7% of the portfolio+440,552 shares
- Capri Holdings Limited~$33.1MNew, 0.0% → 0.9% of the portfolio+1,000,000 shares
- Herbalife Ltd~$29.9MAdded, 0.6% → 1.5% of the portfolio+2,879,603 shares
Largest sells
Since Q1 2024, sized at quarter-end prices.
- Alphabet~$346.3MCut, 12.3% → 5.4% of the portfolio−1,888,064 shares
- Fidelity Natl Information Sv~$156.0MCut, 11.3% → 7.3% of the portfolio−2,069,715 shares
- Liberty Media Corp Del~$73.0MCut, 3.5% → 0.6% of the portfolio−3,292,432 shares
- Liberty Media Corp Del~$46.0MCut, 2.2% → 0.4% of the portfolio−2,077,462 shares
- Warner Bros Discovery Inc~$32.4MSold out, 0.9% → 0.0% of the portfolio−3,713,930 shares
- Theravance Biopharma Inc~$20.3MCut, 1.6% → 1.0% of the portfolio−2,394,105 shares
- Viasat Inc~$16.1MCut, 7.4% → 4.8% of the portfolio−1,271,474 shares
- Altice Usa Inc~$12.5MSold out, 0.3% → 0.0% of the portfolio−4,774,615 shares
- SoundHound AI~$5.6MSold out, 0.2% → 0.0% of the portfolio−1,130,636 shares
- Jacobs Solutions Inc~$1.8MCut, 2.1% → 1.9% of the portfolio−12,568 shares
Holdings
As of Jun 30, 2024; changes in shares since Mar 31, 2024.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Liberty Global LtdCOM CL C · shares 0% · price +1.2% | 20.8% | $755.3M | +$8.9M | ||||||
| Willis Towers Watson Plc LtdSHS · shares +6.2% · price −4.7% | 11.9% | $433.2M | −$20.0M | ||||||
| Crh PlcORD · shares +56% · price −13.1% | 8.7% | $316.9M | −$30.6M | ||||||
| Fidelity Natl Information SvCOM · shares −37% · price +1.6% | 7.3% | $264.5M | +$4.1M | ||||||
| Clarivate PlcORD SHS · shares +27% · price −23.4% | 6.1% | $221.5M | −$53.2M | ||||||
| AlphabetCAP STK CL C · shares −64% · price +20.5% | 5.4% | $196.2M | +$33.3M | ||||||
| Viasat IncCOM · shares −8.5% · price −29.8% | 4.8% | $174.7M | −$74.2M | ||||||
| Humana IncCOM · shares New | 4.3% | $156.9M | — | ||||||
| Jazz Pharmaceuticals PlcSHS USD · shares +53% · price −11.4% | 3.7% | $136.0M | −$11.4M | ||||||
| Wesco Intl IncCOM · shares +290% · price −7.4% | 3.5% | $127.3M | −$2.6M | ||||||
| Liberty Global LtdCOM CL A · shares 0% · price +3.0% | 3.5% | $125.4M | +$3.7M | ||||||
| Outbrain IncNOTE 2.950% 7/2 · shares 0% · price +0.7% | 2.8% | $103.3M | — | ||||||
| Solventum CorpCOM SHS · shares New | 2.6% | $96.2M | — | ||||||
| Willscot Mobil Mini Hldng CoCOM CL A · shares New | 2.6% | $93.0M | — | ||||||
| Eagle Matls IncCOM · shares +31% · price −20.0% | 2.0% | $74.4M | −$14.2M | ||||||
| Fortrea Hldgs IncCOMMON STOCK · shares +934% · price −41.9% | 2.0% | $73.3M | −$5.1M | ||||||
| Jacobs Solutions IncCOM · shares −2.5% · price −9.1% | 1.9% | $69.0M | −$6.9M | ||||||
| Herbalife LtdCOM SHS · shares +128% · price +3.4% | 1.5% | $53.2M | +$763,827 | ||||||
| Gds Hldgs LtdSPONSORED ADS · shares +63% · price +39.7% | 1.1% | $39.5M | +$6.9M | ||||||
| Theravance Biopharma IncCOM · shares −36% · price −5.5% | 0.98% | $35.6M | −$2.1M | ||||||
| Capri Holdings LimitedSHS · shares New | 0.91% | $33.1M | — | ||||||
| Liberty Media Corp DelCOM LBTY SRM S C · shares −76% · price −25.4% | 0.65% | $23.5M | −$8.0M | ||||||
| Verisign IncCOM · shares New | 0.52% | $18.8M | — | ||||||
| Liberty Media Corp DelCOM LBTY SRM S A · shares −78% · price −25.4% | 0.37% | $13.3M | −$4.5M | ||||||
| Total 24 positions | 100% | $3.63B | −$175.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 18 stocks held throughout, down $175.2M (−6.1%).
- Alphabet+$33.3M+20%
- Liberty Global Ltd+$8.9M+1%
- Gds Hldgs Ltd+$6.9M+40%
- Fidelity Natl Information Sv+$4.1M+2%
- Liberty Global Ltd+$3.7M+3%
- Eagle Matls Inc−$14.2M−20%
- Willis Towers Watson Plc Ltd−$20.0M−5%
- Crh Plc−$30.6M−13%
- Clarivate Plc−$53.2M−23%
- Viasat Inc−$74.2M−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |